Tilianin inhibits the human ovarian cancer (PA-1) cell proliferation via blocking cell cycle, inducing apoptosis and inhibiting JAK2/STAT3 signaling pathway

Publication date: Available online 24 June 2021Source: Saudi Journal of Biological SciencesAuthor(s): Chunqiu Xiong, Bingbing Yan, Suhua Xia, Fei Yu, Jingjing Zhao, Hua Bai
Source: Saudi Journal of Biological Sciences - Category: Biology Source Type: research